Search
Home
>>
About Us
>> Webinars
Upcoming Webinars
Past Webinars
Regulatory, Quality & Clinical Due Diligence: The Oft-Overlooked Keys to Successful Transactions.
6-23-2010
Science in the Courtroom.
5-6-2010
Claims-based Marketing and the Importance of Good Science.
4-29-2010
A Look at European Pharmaceutical Regulatory Bodies and Their Interplay with EMEA.
4-14-2010
Recent Sponsor and CRO Warning Letters: What Happened and What We Can Learn
03-10-2010
“Understanding CDRH’s Utilization of New Science in Regulatory Decision-Making.“
2-24-2010
“Best Practices in Finding and Qualifying Expert Witnesses“
2-17-2010
“Understanding What FDA is Looking for in Post Market Safety Assessments: Going Beyond AERS.“
12-16-2009
“A Stricter FDA: How Will it Impact the 510(k) Process?“
12-02-2009
"European Regulation on Advanced Therapies"
10-21-2009
“ANDA vs. 505(b)(2) - When and Why”
9-30-2009
“The Politics of Science - What Corporations Can Learn from NGOs”
9-16-2009
“FDA’s New Strategy on Enforcement – the Growing Perils of Inadequate Compliance"
9-9-2009
“Evaluating Product Risk in a Rapidly Changing Environment”
6-3-2009
“Global Lessons in Developing Biosimilars”
5-27-2009
“FDA Call for Data on non-PMA Class III Devices - Key Points To Consider”
4-20-2009
“Pharmaceutical Development in Europe – Key Points to Consider"
4-15-2009
“The Top Ten Ways to Ensure Successful FDA Meetings"
3-2-2009
“Medical Monitoring: Igniting Future Litigation and Strategies for Defense”
2-19-2009
“The Ten Most Common Obstacles to Meeting Your Development Milestones”
1-29-2009
Home
|
About Us
|
People
|
Lifecycle
|
Service Areas
|
Contact Us
All content ©2009 The Weinberg Group®
Design by Blue Water Media
